Kurzfassung

The development of relevant biomarkers depends crucially on an improved understanding of the mode of action of carcinogens, which for many agents of relevance to human cancer is still largely unknown. Within ECNIS, WP 10 will tackle this problem by combining forces of many teams with different but complementary expertise.